- nVentic Insights | Covid-19 | Case studies | White papers
- Survival of the fittest | nVentic insights
- Back to normal | Covid-19 | nVentic insights
- The new normal | Covid-19 | nVentic insights
- Big pharma inventories in a time of coronavirus
- Get your inventories in shape
- Ultimate guide to reducing excess and obsolete inventory
- Ultimate guide to DIO
- Inventory cover
- Theory and practice of inventory management
- The inventory challenge for the pharmaceutical industry
- The environmental case for inventory optimization
- The limitation of crystal balls in inventory management
- The constantly unrealized potential of inventory optimization
- nVentic Big Pharma inventory trends benchmark report 2019
- The strategic management of inventory
- Strategic supply chain redesign
- Optimizing inventory in a context of supply disruption
- Derisking a component supply chain
- The afterlife of a make vs buy decision
- Reducing inventories by 50% for an industrial manufacturer
- Identifying further potential in inventory optimization
- Reducing inventories while improving service levels